6340 Sequence Drive
San Diego , CA 92121
San Diego , CA 92121
News
-
DexCom Inc. gained 0.9% to $84.89 after the provider of monitoring systems for diabetes management reported an 8% revenue growth in the fourth quarter ending in December.
Revenue increased to $1.11 billion from $1.03 billion, net income fell to $151.7 million from $256.3 million, and earnings per diluted share dropped to 38 cents from 62 cents a year ago.
For fiscal 2025, the company estimated revenue of $4.60 billion, up 14% from $4.03 billion a year ago.
Feb 14, 2025 -
DexCom declined 3.5% to $72.33 despite the company reporting higher-than-expected quarterly earnings, but slower revenue growth weighed on the stock.
Oct 25, 2024
Executive/
Director
Links
Price
- Last Close
-
$ 81.03
$ +2.51 3.2 %
Jan 3, 2025
- 52-Week High/Low
- $140.38 - $67.92
- YTD
- 4.2%
- Trading Volume
- 94,762
- Market Cap Full
- $ 31.3B
- Shares Outstanding
-
386.4M
Oct 19, 2023
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | -17.1% | 41.9% | 29.2% | -0.6% | -5% | -2.7% | -4.9% | 2.6% | 11.8% | 4.2% |
| Q2 | 16.8% | -13.7% | 27.4% | 27.1% | 4% | 18.6% | -85.5% | 10.6% | -5.1% | - |
| Q3 | 10.5% | -33.1% | 45.3% | -2.4% | 8% | 28.7% | 8.1% | -27.4% | 2.3% | - |
| Q4 | -31.9% | 15.6% | -10.4% | 47.5% | -10.3% | -1.7% | 40.6% | 31.2% | 11.4% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 4.2% | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | -2.2% | -5.2% | 20.6% | -5.8% | - | - | - | 2.3% | - | - | - | 0.1% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49% | -27% | -4% | 109% | 82% | 70% | 46% | -79% | 10% | -37% | 4% |
Earnings
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Q1 | 0.23 | 0.49 | -0.28 | -0.3 | 0.21 | 0.41 | 0.23 | 0.12 |
| Q2 | 0.24 | 0.16 | 0.34 | -0.12 | 0.48 | 0.63 | 0.12 | 0.28 |
| Q3 | 0.22 | 0.04 | 0.52 | 0.5 | 0.73 | 0.71 | 0.24 | 0.29 |
| Q4 | 0.09 | 0.10 | -2.02 | 1.02 | 3.64 | -0.2 | 0.23 | - |
| A | 0.8 | 0.8 | -1.4 | 1.1 | 1.3 | 0.5 | 0.8 | 0.69 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Mar | - | 90 | 91.6 | 96.2 | 97.1 | 386.4 |
| Jun | 88.1 | 91.1 | 92.3 | 96.7 | 98.1 | 387.6 |
| Sep | 88.4 | 91.2 | 95.7 | 96.7 | 392.6 | 387.9 |
| Dec | 88.8 | 91.5 | 96 | 96.9 | 386.3 | 386.4 |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Management | ||||||||||||||||||
| Inventory / Stock Turnover | 3.4 | 2.2 | 2.8 | 4.5 | 5.2 | |||||||||||||
| Fixed Asset Turnover | 2.6 | 3.1 | 3.6 | 4.4 | 5.2 | |||||||||||||
| Total Asset Turnover | 0.5 | 0.5 | 0.5 | 0.6 | 0.5 | |||||||||||||
| Leverage | ||||||||||||||||||
| Debt Ratio | 0.3 | 0.5 | 0.5 | 0.5 | 0.6 | |||||||||||||
| Debt – Equity Ratio | 0.6 | 0.8 | 0.9 | 1.2 | 1.5 | |||||||||||||
| Interest Coverage | 7.8 | 2.4 | -1.6 | 3.5 | 3.2 | |||||||||||||
| Equity multiplier | 0.5 | 0.4 | 0.3 | 0.4 | 0.3 | |||||||||||||